Pedmark Approved for Pediatric Cisplatin-Associated Ototoxicity
The FDA has approved Pedmark (sodium thiosulfate) to reduce the risk of ototoxicity associated with cisplatin in pediatric cancer patients.
Source: cancertherapyadvisor.com
Brock Grade News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Brock Grade. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Brock Grade Today - Breaking & Trending Today